Centene Corporation

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, UNH has a market cap of 322.1B. Regarding current trading prices, CNC is priced at $41.82, while UNH trades at $354.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas UNH's P/E ratio is 26.82. In terms of profitability, CNC's ROE is -0.28%, compared to UNH's ROE of +0.12%. Regarding short-term risk, CNC is more volatile compared to UNH. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check UNH's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CNC is priced at $41.82, while ANTM trades at $482.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CNC's ROE is -0.28%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, CNC is more volatile compared to ANTM. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check ANTM's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, CVS has a market cap of 99.1B. Regarding current trading prices, CNC is priced at $41.82, while CVS trades at $77.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas CVS's P/E ratio is 56.06. In terms of profitability, CNC's ROE is -0.28%, compared to CVS's ROE of +0.02%. Regarding short-term risk, CNC is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check CVS's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, ELV has a market cap of 74.9B. Regarding current trading prices, CNC is priced at $41.82, while ELV trades at $344.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas ELV's P/E ratio is 14.60. In terms of profitability, CNC's ROE is -0.28%, compared to ELV's ROE of +0.12%. Regarding short-term risk, CNC is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check ELV's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, CI has a market cap of 73.6B. Regarding current trading prices, CNC is priced at $41.82, while CI trades at $275.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas CI's P/E ratio is 12.43. In terms of profitability, CNC's ROE is -0.28%, compared to CI's ROE of +0.15%. Regarding short-term risk, CNC is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check CI's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, HUM has a market cap of 26B. Regarding current trading prices, CNC is priced at $41.82, while HUM trades at $215.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas HUM's P/E ratio is 21.85. In terms of profitability, CNC's ROE is -0.28%, compared to HUM's ROE of +0.07%. Regarding short-term risk, CNC is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check HUM's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, MOH has a market cap of 9.2B. Regarding current trading prices, CNC is priced at $41.82, while MOH trades at $175.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas MOH's P/E ratio is 47.31. In terms of profitability, CNC's ROE is -0.28%, compared to MOH's ROE of +0.04%. Regarding short-term risk, CNC is less volatile compared to MOH. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check MOH's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, OSCR has a market cap of 4.4B. Regarding current trading prices, CNC is priced at $41.82, while OSCR trades at $16.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas OSCR's P/E ratio is -9.95. In terms of profitability, CNC's ROE is -0.28%, compared to OSCR's ROE of -0.39%. Regarding short-term risk, CNC is more volatile compared to OSCR. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check OSCR's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, ALHC has a market cap of 4.3B. Regarding current trading prices, CNC is priced at $41.82, while ALHC trades at $21.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas ALHC's P/E ratio is -192.09. In terms of profitability, CNC's ROE is -0.28%, compared to ALHC's ROE of -0.00%. Regarding short-term risk, CNC is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check ALHC's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, CLOV has a market cap of 1.2B. Regarding current trading prices, CNC is priced at $41.82, while CLOV trades at $2.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas CLOV's P/E ratio is -14.29. In terms of profitability, CNC's ROE is -0.28%, compared to CLOV's ROE of -0.26%. Regarding short-term risk, CNC is less volatile compared to CLOV. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check CLOV's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CNC is priced at $41.82, while BHG trades at $16.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas BHG's P/E ratio is -0.12. In terms of profitability, CNC's ROE is -0.28%, compared to BHG's ROE of -0.70%. Regarding short-term risk, CNC is less volatile compared to BHG. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check BHG's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, CABR has a market cap of 16.5M. Regarding current trading prices, CNC is priced at $41.82, while CABR trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas CABR's P/E ratio is -2.43. In terms of profitability, CNC's ROE is -0.28%, compared to CABR's ROE of -3.00%. Regarding short-term risk, CNC is less volatile compared to CABR. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check CABR's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, BMGL has a market cap of 11.6M. Regarding current trading prices, CNC is priced at $41.82, while BMGL trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas BMGL's P/E ratio is -1.38. In terms of profitability, CNC's ROE is -0.28%, compared to BMGL's ROE of -1.95%. Regarding short-term risk, CNC is more volatile compared to BMGL. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check BMGL's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, MRAI has a market cap of 4.8M. Regarding current trading prices, CNC is priced at $41.82, while MRAI trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas MRAI's P/E ratio is -0.09. In terms of profitability, CNC's ROE is -0.28%, compared to MRAI's ROE of +0.52%. Regarding short-term risk, CNC is less volatile compared to MRAI. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check MRAI's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, NIVF has a market cap of 1.1M. Regarding current trading prices, CNC is priced at $41.82, while NIVF trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas NIVF's P/E ratio is 0.05. In terms of profitability, CNC's ROE is -0.28%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CNC is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check NIVF's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CNC is priced at $41.82, while UAM trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas UAM's P/E ratio is N/A. In terms of profitability, CNC's ROE is -0.28%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CNC is more volatile compared to UAM. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check UAM's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CNC is priced at $41.82, while GTS trades at $35.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas GTS's P/E ratio is 10.41. In terms of profitability, CNC's ROE is -0.28%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CNC is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check GTS's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CNC is priced at $41.82, while MGLN trades at $94.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CNC's ROE is -0.28%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CNC is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check MGLN's competition here

CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNC stands at 20.6B. In comparison, AET has a market cap of 0. Regarding current trading prices, CNC is priced at $41.82, while AET trades at $106.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNC currently has a P/E ratio of -3.09, whereas AET's P/E ratio is N/A. In terms of profitability, CNC's ROE is -0.28%, compared to AET's ROE of +0.11%. Regarding short-term risk, CNC is more volatile compared to AET. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check AET's competition here